These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23748985)

  • 41. Androgenic properties of the dietary supplement 5α-hydroxy-laxogenin.
    Beer C; Keiler AM
    Arch Toxicol; 2022 Jul; 96(7):2139-2142. PubMed ID: 35344071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attitudes towards use of anabolic-androgenic steroids among Ghanaian high school students.
    Sagoe D; Torsheim T; Molde H; Andreassen CS; Pallesen S
    Int J Drug Policy; 2015 Feb; 26(2):169-74. PubMed ID: 25465347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden.
    Nilsson S; Baigi A; Marklund B; Fridlund B
    Eur J Public Health; 2001 Jun; 11(2):195-7. PubMed ID: 11420810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The medical aspect of using anabolic androgenic steroids in males attending gyms of Saint-Petersburg].
    Lykhonosov MP; Babenko AY
    Probl Endokrinol (Mosk); 2019 May; 65(1):19-30. PubMed ID: 31091047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aggression and Anabolic-Androgenic Steroid Use Intent in Adolescents: A Longitudinal Study.
    Chegeni R; Sagoe D; Mentzoni RA; Pallesen S
    Subst Use Misuse; 2019; 54(9):1509-1518. PubMed ID: 30931688
    [No Abstract]   [Full Text] [Related]  

  • 46. Anabolic steroids.
    Kuhn CM
    Recent Prog Horm Res; 2002; 57():411-34. PubMed ID: 12017555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Adolescents Training and Learning to Avoid Steroids (ATLAS) prevention program. Background and results of a model intervention.
    Goldberg L; Elliot DL; Clarke GN; MacKinnon DP; Zoref L; Moe E; Green C; Wolf SL
    Arch Pediatr Adolesc Med; 1996 Jul; 150(7):713-21. PubMed ID: 8673196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reliable identification and quantification of anabolic androgenic steroids in dietary supplements by using gas chromatography coupled to triple quadrupole mass spectrometry.
    Micalizzi G; Huszti K; Pálinkás Z; Mandolfino F; Martos É; Dugo P; Mondello L; Utczás M
    Drug Test Anal; 2021 Jan; 13(1):128-139. PubMed ID: 32959986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Androgenic anabolic steroid use among male adolescents in Falkenberg.
    Nilsson S
    Eur J Clin Pharmacol; 1995; 48(1):9-11. PubMed ID: 7621856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of anabolic-androgenic steroids among body builders--frequency and attitudes.
    Lindström M; Nilsson AL; Katzman PL; Janzon L; Dymling JF
    J Intern Med; 1990 Jun; 227(6):407-11. PubMed ID: 2351927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usage and perceptions of anabolic-androgenic steroids among male fitness centre attendees in Kuwait--a cross-sectional study.
    Alsaeed I; Alabkal JR
    Subst Abuse Treat Prev Policy; 2015 Aug; 10():33. PubMed ID: 26296560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anabolic-androgenic steroids and psychiatric-related effects: a review.
    Uzych L
    Can J Psychiatry; 1992 Feb; 37(1):23-8. PubMed ID: 1551042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting future anabolic-androgenic steroid use intentions with current substance use: findings from an internet-based survey.
    Dunn M; Mazanov J; Sitharthan G
    Clin J Sport Med; 2009 May; 19(3):222-7. PubMed ID: 19423975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
    Anawalt BD
    Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anabolic-androgenic steroid use and correlates in Norwegian adolescents.
    Sandvik MR; Bakken A; Loland S
    Eur J Sport Sci; 2018 Jul; 18(6):903-910. PubMed ID: 29635967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nutritional supplements cross-contaminated and faked with doping substances.
    Geyer H; Parr MK; Koehler K; Mareck U; Schänzer W; Thevis M
    J Mass Spectrom; 2008 Jul; 43(7):892-902. PubMed ID: 18563865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters.
    Curry LA; Wagman DF
    Percept Mot Skills; 1999 Feb; 88(1):224-33. PubMed ID: 10214647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical review 31: Anabolic-androgenic steroids and athletes: what are the issues?
    Rogol AD; Yesalis CE
    J Clin Endocrinol Metab; 1992 Mar; 74(3):465-9. PubMed ID: 1740476
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of high school sports participation on the use of performance-enhancing substances in young adulthood.
    Dodge TL; Jaccard JJ
    J Adolesc Health; 2006 Sep; 39(3):367-73. PubMed ID: 16919798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.